-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Q2 Earnings Forecast for MLTX Issued By Leerink Partnrs
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of MoonLake Immunotherapeutics in a research report issued on Thursday, February 27th. Leerink Partnrs analyst T. Smith forecasts that the company will earn ($0.82) per share for the quarter. The consensus estimate for MoonLake Immunotherapeutics’ current […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of MoonLake Immunotherapeutics in a research report issued on Thursday, February 27th. Leerink Partnrs analyst T. Smith forecasts that the company will earn ($0.82) per share for the quarter. The consensus estimate for MoonLake Immunotherapeutics’ current […]
